Short answer · Medically reviewed summary · Last updated: 2023-07-13
I Cell Disease is a rare genetic disorder that falls under the category of lysosomal storage diseases. It is also known as mucolipidosis II (ML II) or inclusion cell disease.
I Cell Disease is a rare genetic disorder that falls under the category of lysosomal storage diseases. It is also known as mucolipidosis II (ML II) or inclusion cell disease. This condition is characterized by the improper functioning of lysosomes, which are responsible for breaking down waste materials within cells.
Individuals with I Cell Disease experience a range of symptoms including skeletal abnormalities, developmental delays, intellectual disability, and distinct facial features. The disease affects multiple organs and systems, leading to various complications such as heart problems, respiratory issues, and impaired growth.
Diagnosis of I Cell Disease typically occurs in infancy or early childhood through clinical evaluation, genetic testing, and analysis of urine samples. Unfortunately, there is currently no cure for this condition. Treatment mainly focuses on managing symptoms and improving quality of life through supportive care, physical therapy, and medications to alleviate specific symptoms.
Given the complexity and rarity of I Cell Disease, it is crucial for affected individuals and their families to work closely with healthcare professionals and support organizations to ensure comprehensive care and access to available resources.